Maharashtra FDA Seizes ₹1.38 Crore in Health Supplements Amid Steroid Concerns
The Maharashtra FDA has intensified regulations on health supplements, seizing over ₹1.38 crore worth of products suspected of containing undeclared steroids.
FDA's crackdown involved inspections at 17 locations across six divisions.
Seizures included products with rejected ingredients, raising safety concerns.
New regulations require all sellers to obtain proper licenses and prohibit misleading health claims.
In a significant move to enhance consumer safety, the Maharashtra Food and Drug Administration (FDA) has seized health supplements worth ₹1.38 crore amid concerns of undeclared steroids. This action, taken on November 13, involved inspections at 17 establishments across six divisions, including Pune, Nashik, and Nagpur, as part of a statewide initiative to tighten regulations on health supplements and nutraceuticals.
The FDA's order, issued by Commissioner Tukaram Mundhe, mandates immediate compliance across the entire supply chain, which encompasses manufacturers, distributors, pharmacies, and e-commerce platforms. The focus is particularly on products related to sports nutrition, weight loss, and sexual wellness, where there are suspicions of unsafe and misbranded items. Inspections revealed that some manufacturers were using ingredients like Magnesium Acetyl Taurate and Nicotinamide Mononucleotide, which had previously been rejected by the Food Safety and Standards Authority of India (FSSAI).
During the inspections, the FDA confiscated products valued at ₹1,38,95,852 and has sent samples for laboratory analysis to assess their safety and compliance. The highest seizure occurred in Nagpur, amounting to ₹57.30 lakh, followed by ₹47.65 lakh in the Konkan division and ₹30.57 lakh in Pune. The FDA is awaiting further analysis before determining the next steps, which may include legal action against violators.
Under the new regulations, all businesses involved in the manufacturing or sale of health supplements must secure the appropriate FSSAI licenses, clearly indicating the specific food category. Pharmacies and gyms selling these products are also required to obtain food licenses, even if they possess other types of licenses. Furthermore, the FDA has prohibited any claims that these products can treat or prevent diseases, alongside restrictions on advertising practices.
The FDA's initiative affects approximately 1,100 licensed food businesses in Maharashtra, including manufacturers and relabellers. The agency plans to conduct more risk-based inspections, particularly targeting sports nutrition and imported products. Non-compliance could lead to severe penalties, including fines of up to ₹10 lakh for misleading advertisements or operating without a license. The FDA's actions underscore a commitment to ensuring the safety and efficacy of health supplements in the state.




